Benchmark Is Bullish On Middleby, Sees Notable Upside

Benchmark analyst Todd Brooks initiated coverage on Middleby Corp (NASDAQ:MIDD) with a Buy rating and a price target of $190, implying an upside…
  • Benchmark analyst Todd Brooks initiated coverage on Middleby Corp (NASDAQ:MIDD) with a Buy rating and a price target of $190, implying an upside of 26%.
  • The analyst predicts that the company’s backlogs and accelerating demand for equipment-based solutions will provide a multi-year revenue tailwind.
  • Meanwhile, the analyst sees solid demand trends across the company’s Commercial Foodservice and Food Processing segments are balanced by a recent softening of lead indicators in the Residential Kitchen segment.
  • Price Action: MIDD shares are trading lower by 1.23% at $150.88 on the last check Friday.
Total
0
Shares
Related Posts
Read More

Marijuana Giant Trulieve Boosts Cash Position With $25M Loan, Opens Cannabis Stores In Florida

Florida-based medical cannabis firm Trulieve Cannabis has secured $25m of gross proceeds from a five-year loan. The company will pay interest of 8.31% until the loan matures. The deal, arranged with First Federal bank, gives Trulieve greater flexibility, according to CEO Kim Rivers. She said the loan would boost the company's cash position as it gears up for growth opportunities. The company revealed the financing at the same time as the opening of two new medical dispensaries in Florida: one in Crawfordville and another in Crestview. Trulieve will stock products from in-house brands Modern Flower, Muse, Trekkers and many others. The dispensaries will also carry product from partner brands, including Alien Labs.

CSE:TRUL